2,078
Views
17
CrossRef citations to date
0
Altmetric
Review Article

New business models for antibiotic innovation

&
Pages 176-180 | Received 09 Jan 2014, Accepted 24 Feb 2014, Published online: 19 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

S E Edwards & C M Morel. (2019) Learning from our mistakes: using key opportunities to remove the perverse incentives that help drive antibiotic resistance. Expert Review of Pharmacoeconomics & Outcomes Research 19:6, pages 685-692.
Read now
Otto Cars. (2014) Securing access to effective antibiotics for current and future generations. Whose responsibility?. Upsala Journal of Medical Sciences 119:2, pages 209-214.
Read now

Articles from other publishers (14)

Myrto Barmpouni, Jason P. Gordon, Ryan L. Miller, Clive R. J. Pritchard, James W. Dennis, Vassilis Grammelis, Aris Rousakis, Kyriakos Souliotis, Garyphallia Poulakou, George L. Daikos & Amer Al-Taie. (2022) Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options. Infectious Diseases and Therapy 12:2, pages 527-543.
Crossref
Otto Cars, Sujith J Chandy, Mirfin Mpundu, Arturo Quizhpe Peralta, Anna Zorzet & Anthony D So. (2021) Resetting the agenda for antibiotic resistance through a health systems perspective. The Lancet Global Health 9:7, pages e1022-e1027.
Crossref
Nadine T Hillock, Tracy L Merlin, Jonathan Karnon, John Turnidge & Jaklin Eliott. (2020) Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study. JAC-Antimicrobial Resistance 2:2.
Crossref
Jonathan NorthAnthony D. So & Reshma Ramachandran. 2020. Challenges to Tackling Antimicrobial Resistance. Challenges to Tackling Antimicrobial Resistance 207 240 .
Jonathan North. 2020. Challenges to Tackling Antimicrobial Resistance. Challenges to Tackling Antimicrobial Resistance.
Sabine Vogler. 2020. Global Pharmaceutical Policy. Global Pharmaceutical Policy 99 137 .
Simone Pisano, Matteo Giustiniani, Lewis Francis, Deyarina Gonzalez, Lavinia Margarit, I. Martin Sheldon, Donatella Paolino, Massimo Fresta, R. Steven Conlan & Gareth D. Healey. (2019) Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract. Biomedical Microdevices 21:2.
Crossref
Sabine Vogler. 2019. Medicine Price Surveys, Analyses and Comparisons. Medicine Price Surveys, Analyses and Comparisons 369 419 .
Cecilia Kållberg, Christine Årdal, Hege Salvesen Blix, Eili Klein, Elena M. Martinez, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen & Ramanan Laxminarayan. (2018) Introduction and geographic availability of new antibiotics approved between 1999 and 2014. PLOS ONE 13:10, pages e0205166.
Crossref
Ben Parsonage, Philip K. Hagglund, Lloyd Keogh, Nick Wheelhouse, Richard E. Brown & Stephanie J. Dancer. (2017) Control of Antimicrobial Resistance Requires an Ethical Approach. Frontiers in Microbiology 8.
Crossref
Mark A. Turner & Steven Hirschfeld. (2017) Frameworks for Evaluating Medicines in Children. Clinical Therapeutics 39:10, pages 1949-1958.
Crossref
Matthew J Renwick, David M Brogan & Elias Mossialos. (2015) A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. The Journal of Antibiotics 69:2, pages 73-88.
Crossref
Marc Mendelson, John-Arne Røttingen, Unni Gopinathan, Davidson H Hamer, Heiman Wertheim, Buddha Basnyat, Christopher Butler, Göran Tomson & Manica Balasegaram. (2016) Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. The Lancet 387:10014, pages 188-198.
Crossref
Steven J HoffmanKevin OuttersonJohn-Arne R?ttingenOtto CarsCharles CliftZain RizviFiona RotbergG?ran TomsonAnna Zorzet. (2015) An international legal framework to address antimicrobial resistance. Bulletin of the World Health Organization 93:2, pages 66-66.
Crossref